Studies a Connecticut Option for affordable health care, requires insurers to cover certain generic drugs, and provides tax credits for small.
Studies the feasibility of a Connecticut Option for affordable health care, including its design elements and impact on individuals. Requires health insurers to cover generic drugs and biosimilars if they are marketed at a lower cost than the reference product. Provides tax credits for small businesses that offer individual coverage health reimbursement arrangements. Establishes procedures for paying health carriers offering qualified health plans.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.